Analyst consensus rating
Twist Bioscience Analyst Rating: Buy
TWST is rated Buy by 10 analysts with a $105.30 target. As of 2026-08-27.
Direct answer
Twist Bioscience's consensus rating is Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $105.30.
Forecast evidence checked August 27, 2026.
Get free Twist Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $150.06
- Average price target
- $105.30
- High price target
- $120.00
- Low price target
- $36.00
- Low target gap
- -76%
- Target upside
- -29.8%
- High target gap
- -20%
- Target range width
- 56%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Twist Bioscience?
Twist Bioscience has a verified Buy consensus. The same dataset has an average price target of $105.30.
How far are Twist Bioscience's low and high targets from the recorded price?
The low target implies -76%, while the high target implies -20%.
How many analysts are included in Twist Bioscience's consensus?
The verified consensus includes 10 analysts.
How is Twist Bioscience's target upside or downside calculated?
The average target of $105.30 is divided by the recorded price of $150.06, then one is subtracted to produce -29.8%. This does not guarantee a future return.
When was Twist Bioscience's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.